BrightSpring Health Services

BTSG

Market cap $14.2B

LOUISVILLE, Ky., July 08, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its second quarter 2026 financial results on Friday, July 31, 2026, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day.

Does BrightSpring Health Services, Inc. (BTSG) have what it takes to be a top stock pick for momentum investors? Let's find out.

BTSG's specialty, infusion and provider services momentum support growth, but IRA pressures and integration risks may weigh on margins.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

If you are looking for stocks that are well positioned to maintain their recent uptrend, BrightSpring Health Services, Inc. (BTSG) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Let's take a look at four stocks, BTSG, KNSA, ATI and VMI, with stellar net profit margins and rising EPS estimates that can help create a winning portfolio.

BrightSpring, Dycom, StoneX and Orion stand out as buy-worthy stocks, backed by rising cash flows and upward earnings estimate revisions.

Here is how BrightSpring Health Services, Inc. (BTSG) and Bioventus (BVS) have performed compared to their sector so far this year.

Medical stocks like Centene, DaVita and BrightSpring could rally as SpaceX IPO-fueled market optimism lifts broader sector sentiment.

BrightSpring, StoneX, Cimpress and Flexsteel stand out as buy-worthy stocks with rising cash flows and upward earnings estimate revisions.